Department of Surgery, State University of New York, Downstate Health Sciences University, Brooklyn, NY.
Operative Care Line/Research Service Line, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX.
Ann Surg. 2022 Sep 1;276(3):554-561. doi: 10.1097/SLA.0000000000005552. Epub 2022 Jul 15.
Studies indicate that coronavirus disease 2019 (COVID-19) infection before or soon after operations increases mortality, but they do not comment on the appropriate timing for interventions after diagnosis.
We sought to determine what the safest time would be for COVID-19 diagnosed patients to undergo major operative interventions.
High-risk operations, between January 2020 and May 2021, were identified from the Veterans Affairs COVID-19 Shared Data Resource. Current Procedural Terminology (CPT) codes were used to exact match COVID-19 positive cases (n=938) to negative controls (n=7235). Time effects were calculated as a continuous variable and then grouped into 2-week intervals. The primary outcome was 90-day, all-cause postoperative mortality.
Ninety-day mortality in cases and controls was similar when the operation was performed within 9 weeks or longer after a positive test; but significantly higher in cases versus controls when the operation was performed within 7 to 8 weeks (12.3% vs 4.9%), 5 to 6 weeks (10.3% vs 3.3%), 3 to 4 weeks (19.6% vs 6.7%), and 1 to 2 weeks (24.7% vs 7.4%) from diagnosis. Among patients who underwent surgery within 8 weeks from diagnosis, 90-day mortality was 16.6% for cases versus 5.8% for the controls ( P <0.001). In this cohort, we assessed interaction between case status and any symptom ( P =0.93), and case status and either respiratory symptoms or fever ( P =0.29), neither of which were significant statistically.
Patients undergoing major operations within 8 weeks after a positive test have substantially higher postoperative 90-day mortality than CPT-matched controls without a COVID-19 diagnosis, regardless of presenting symptoms.
研究表明,2019 年冠状病毒病(COVID-19)感染发生在手术前或手术后不久会增加死亡率,但它们并未对诊断后干预的适当时间发表评论。
我们试图确定 COVID-19 确诊患者接受重大手术干预的最安全时间。
从退伍军人事务部 COVID-19 共享数据资源中确定 2020 年 1 月至 2021 年 5 月期间的高危手术。使用当前程序术语 (CPT) 代码将 COVID-19 阳性病例(n=938)与阴性对照(n=7235)精确匹配。时间效应被计算为连续变量,然后分为 2 周间隔。主要结局是 90 天全因术后死亡率。
在阳性测试后 9 周或更长时间内进行手术时,病例和对照组的 90 天死亡率相似;但在阳性测试后 7 至 8 周(12.3%比 4.9%)、5 至 6 周(10.3%比 3.3%)、3 至 4 周(19.6%比 6.7%)和 1 至 2 周(24.7%比 7.4%)时,病例组的死亡率明显高于对照组。在诊断后 8 周内接受手术的患者中,病例组的 90 天死亡率为 16.6%,对照组为 5.8%(P<0.001)。在该队列中,我们评估了病例状态与任何症状之间的相互作用(P=0.93),以及病例状态与呼吸症状或发热之间的相互作用(P=0.29),两者均无统计学意义。
与未诊断 COVID-19 的 CPT 匹配对照组相比,阳性测试后 8 周内接受重大手术的患者术后 90 天死亡率明显更高,无论是否存在症状。